83 related articles for article (PubMed ID: 7823610)
1. Rectal epithelial cell proliferation: comparison of errors of measurement with inter-subject variance. Australian Polyp Prevention Project Investigators.
Macrae FA; Kilias D; Sharpe K; Hughes N; Young GP; MacLennan R
J Cell Biochem Suppl; 1994; 19():84-90. PubMed ID: 7823610
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry.
Lyles CM; Sandler RS; Keku TO; Kupper LL; Millikan RC; Murray SC; Bangdiwala SI; Ulshen MH
Cancer Epidemiol Biomarkers Prev; 1994; 3(7):597-605. PubMed ID: 7827591
[TBL] [Abstract][Full Text] [Related]
3. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.
Bostick RM; Fosdick L; Lillemoe TJ; Overn P; Wood JR; Grambsch P; Elmer P; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):931-42. PubMed ID: 9367067
[TBL] [Abstract][Full Text] [Related]
4. Rectal mucosal proliferation, dietary factors, and the risk of colorectal adenomas.
Keku TO; Galanko JA; Murray SC; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):993-9. PubMed ID: 9829707
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological use of rectal proliferation measures.
Baron JA; Wargovich MJ; Tosteson TD; Sandler R; Haile R; Summers R; van Stolk R; Rothstein R; Weiss J
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):57-61. PubMed ID: 7894325
[TBL] [Abstract][Full Text] [Related]
6. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine.
Kilias D; Macrae FA; Sharpe K; Young GP
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):819-24. PubMed ID: 9332765
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection.
Murray SC; Sandler RS; Keku TO; Lyles CM; Millikan RC; Bangdiwala SI; Kupper LL; Jiang W; Ulshen MH
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):715-20. PubMed ID: 8672987
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?
McShane LM; Kulldorff M; Wargovich MJ; Woods C; Purewal M; Freedman LS; Corle DK; Burt RW; Mateski DJ; Lawson M; Lanza E; O'Brien B; Lake W; Moler J; Schatzkin A
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):605-12. PubMed ID: 9681529
[TBL] [Abstract][Full Text] [Related]
9. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.
Sandler RS; Baron JA; Tosteson TD; Mandel JS; Haile RW
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):653-6. PubMed ID: 10919733
[TBL] [Abstract][Full Text] [Related]
10. Calcium supplements interact significantly with long-term diet while suppressing rectal epithelial proliferation of adenoma patients.
Rozen P; Lubin F; Papo N; Knaani J; Farbstein H; Farbstein M; Zajicek G
Cancer; 2001 Feb; 91(4):833-40. PubMed ID: 11241253
[TBL] [Abstract][Full Text] [Related]
11. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer.
Anti M; Marra G; Percesepe A; Armelao F; Gasbarrini G
J Cell Biochem Suppl; 1994; 19():68-75. PubMed ID: 7823608
[TBL] [Abstract][Full Text] [Related]
12. Measuring cell proliferation in the rectal mucosa. comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays.
Kulldorff M; McShane LM; Schatzkin A; Freedman LS; Wargovich MJ; Woods C; Purewal M; Burt RW; Lawson M; Mateski DJ; Lanza E; Corle DK; O'Brien B; Moler J
J Clin Epidemiol; 2000 Aug; 53(8):875-83. PubMed ID: 10942872
[TBL] [Abstract][Full Text] [Related]
13. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
Risio M; Candelaresi G; Rossini FP
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
[TBL] [Abstract][Full Text] [Related]
15. Quantification of proliferating cell nuclear antigen in large intestinal crypt by computer-assisted image analysis.
Lin HC; Sotnikov AV; Fosdick L; Bostick RM; Willett WC
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):109-14. PubMed ID: 8850271
[TBL] [Abstract][Full Text] [Related]
16. The effect of a low-fat, high fiber, fruit and vegetable intervention on rectal mucosal proliferation.
Pfeiffer R; McShane L; Wargovich M; Burt R; Kikendall W; Lawson M; Lanza E; Schatzkin A
Cancer; 2003 Sep; 98(6):1161-8. PubMed ID: 12973839
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
18. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients.
Bostick RM; Fosdick L; Grandits GA; Lillemoe TJ; Wood JR; Grambsch P; Louis TA; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1011-9. PubMed ID: 9419396
[TBL] [Abstract][Full Text] [Related]
19. Selenium and colorectal adenoma: results of a pooled analysis.
Jacobs ET; Jiang R; Alberts DS; Greenberg ER; Gunter EW; Karagas MR; Lanza E; Ratnasinghe L; Reid ME; Schatzkin A; Smith-Warner SA; Wallace K; Martínez ME
J Natl Cancer Inst; 2004 Nov; 96(22):1669-75. PubMed ID: 15547179
[TBL] [Abstract][Full Text] [Related]
20. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
